Literature DB >> 28888401

Detection of carbapenemases and other mechanisms of enzymatic resistance to β-lactams in Enterobacteriaceae with diminished susceptibility to carbapenems in a tertiary care hospital.

Marta Gómara1, Ana Isabel López-Calleja2, Berta María Pilar Vela Iglesia2, Isabel Ferrer Cerón2, Antonio Rezusta López2, María José Revillo Pinilla2.   

Abstract

INTRODUCTION: Our objective was to characterize the enzymatic β-lactam resistance in clinical Enterobacteriaceae isolates with diminished susceptibility to carbapenems from 2013 to 2014 at Hospital Universitario Miguel Servet. MATERIAL/
METHODS: A total of 63 clinical isolates were analyzed for the presence of carbapenemases (KPC, OXA-48 and MBL), ESBLs and AmpC enzymes by combined disk methods and PCR detection of carbapenemase-encoding and beta-lactamase-encoding genes.
RESULTS: Fifteen isolates had a phenotypic test compatible with carbapenemase production; two of these were confirmed by PCR as OXA-48 producers. ESBL detection was positive in 27 isolates (43%); plasmid-mediated AmpC was detected in nine isolates (14.2%) and derepressed AmpC β-lactamase was present in 18 isolates (28%).
CONCLUSION: During the study period, the decreased susceptibility to carbapenems in Enterobacteriaceae in our area was not due to true carbapenemases but rather to β-lactamase activity (82.5% were ESBL or AmpC producers), probably in combination with decreased permeability of the outer membrane.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Biología molecular; Carbapenemasa; Carbapenemase; Enterobacteriaceae; Molecular biology; Resistencia antibiótica

Mesh:

Substances:

Year:  2017        PMID: 28888401     DOI: 10.1016/j.eimc.2017.07.006

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  6 in total

Review 1.  Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens.

Authors:  Flora Cruz-López; Adrian Martínez-Meléndez; Rayo Morfin-Otero; Eduardo Rodriguez-Noriega; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Front Cell Infect Microbiol       Date:  2022-05-20       Impact factor: 6.073

2.  Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia.

Authors:  Saba Gebremichael Tekele; Dejenie Shiferaw Teklu; Kassu Desta Tullu; Samuel Kinde Birru; Melese Hailu Legese
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

3.  Prevalence of plasmid-mediated AmpC β-lactamases among uropathogenic Escherichia coli isolates in southwestern Iran.

Authors:  Nabi Jomehzadeh; Khadijeh Ahmadi; Zahra Rahmani
Journal:  Osong Public Health Res Perspect       Date:  2021-12-01

4.  Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates.

Authors:  Mona Shaaban; Soha Lotfy Elshaer; Ola A Abd El-Rahman
Journal:  BMC Microbiol       Date:  2022-10-11       Impact factor: 4.465

5.  Multidrug-Resistant and Carbapenemase-Producing Enterobacteriaceae in Addis Ababa, Ethiopia.

Authors:  Saba Gebremichael Tekele; Dejenie Shiferaw Teklu; Melese Hailu Legese; Daniel Gebretsadik Weldehana; Melaku Ashagrie Belete; Kassu Desta Tullu; Samuel Kinde Birru
Journal:  Biomed Res Int       Date:  2021-06-11       Impact factor: 3.411

6.  Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC.

Authors:  Enrique Rodríguez-Guerrero; Juan Carlos Callejas-Rodelas; José María Navarro-Marí; José Gutiérrez-Fernández
Journal:  Microorganisms       Date:  2022-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.